Epidemiological characteristics and prevalence rates of research reproducibility across disciplines: A scoping review of articles published in 2018-2019
Figures
Tables
Table 1
Characteristics of included documents.
Characteristic | Categories | All studies | Single replication papers(N=36) | Multiple replication papers(N=11) |
---|---|---|---|---|
N (%) (unless otherwise indicated) | ||||
What discipline does the work best fit in?* | Biomedicine Economics Education Health sciences Psychology Other (mixture of two or more of the abov1e) | 6 (3.4) 5 (2.8) 5 (2.8) 42 (23.7) 86 (48.6) 33 (18.6) | 6 (16.7) 5 (13.9) 1 (2.8) 9 (25.0) 15 (41.7) - | - - 1 (9.1) 4 (36.4) 4 (36.4) 2 (18.2) |
Year of publication | 2018 2019 | 28 (59.6) 19 (40.4) | 21 (58.3) 15 (41.7) | 7 (63.6) 4 (36.4) |
Country of corresponding author (reported based on Top 3 overall) | USA The Netherlands Australia | 27 (57.4) 4 (8.5) 3 (6.4) | 19 (52.8) 3 (8.3) 3 (8.3) | 8 (72.7) 1 (9.1) - |
Number of authors† | Median Range | 3 1–172 | 3 1–124 | 4 1–172 |
Funding | Yes No Not reported | 32 (68.1) 6 (12.8) 9 (19.1) | 23 (63.9) 5 (13.9) 8 (22.2) | 9 (81.8) 1 (9.1) 1 (9.1) |
Funding source‡ | Government Academic Non-profit Unsure | 19 (59.4) 15 (46.9) 14 (43.8) 1 (3.1) | 17 (73.9) 9 (39.1) 9 (39.1) - | 2 (22.2) 6 (66.7) 5 (55.6) 1 (11.1) |
Ethics approval | Yes No Ethics approval not relevant | 23 (48.9) 10 (21.3) 14 (29.8) | 17 (47.2) 8 (22.2) 11 (30.6) | 6 (54.5) 2 (18.2) 3 (27.3) |
-
*
Data reported at the study level.
-
†
Data reports median and range.
-
‡
Data refers to funded studies only, some studies report multiple funding sources.
Table 2
Study replication methods characteristics.
Characteristic | Categories | All discipline studies(N=177) | BiomedicineN (%) | EconomicsN (%) | EducationN (%) | Health sciences*N (%) | PsychologyN (%) | Other (mixture of two or more of the above)N (%) |
---|---|---|---|---|---|---|---|---|
Did the replication study team specify that they contacted the original study project team? | Yes, the author teams overlapped Yes, there was contact No, the teams did not overlap or contact | 16 (9.0) 44 (24.9) 117 (66.1) | 2 (33.3) - 4 (66.7) | - - 5 (100) | - - 5 (100) | 4 (9.5) 14 (33.3) 24 (57.1) | 10 (11.6) 9 (10.5) 67 (77.9) | - 21 (63.6) 12 (36.4) |
Does the replication study refer to a protocol that was registered prior to data collection? | Yes No | 81 (45.8) 96 (54.2) | 2 (33.3) 4 (66.7) | - 5 (100) | 1 (20.0) 4 (80.0) | 18 (42.9) 24 (57.1) | 39 (45.3) 47 (54.7) | 21 (63.6) 12 (36.4) |
Do the authors specify that they used an identical protocol? | Yes No † Not reported Unsure | 41 (23.2) 70 (39.5) 64 (36.2) 2 (1.1) | 2 (33.3) 1 (16.7) - 2 (33.3) | 1 (20.0) 3 (60.0) 1 (20.0) - | - 3 (60.0) 2 (40.0) - | 9 (21.4) 15 (35.7) 17 (40.5) - | 8 (9.3) 34 (39.5) 44 (51.2) - | 21 (63.6) 12 (36.64) - - |
Does the study indicate that data is shared publicly? | Yes‡ No | 112 (63.3) 65 (36.7) | 2 (33.3) 4 (66.7) | - 5 (100) | 1 (20.0) 4 (80.0) | 18 (42.9) 24 (57.1) | 70 (81.4) 16 (18.6) | 21 (63.6) 12 (36.4) |
What is the study design used? | Data re-analysis Experimental Observational Trial | 35 (19.8) 52 (29.4) 85 (48.0) 5 (2.8) | - 2 (33.3) 3 (50.0) 1 (16.7) | 3 (60.0) 1 (20.0) 1 (20.0) - | 1 (20.0) - 3 (60.0) 1 (20.0) | 26 (61.9) 10 (23.8) 3 (7.1) 3 (7.1) | 5 (5.8) 39 (45.3) 42 (48.8) - | 33 (100) - |
Did the study specify a primary outcome? | Yes No | 43 (24.3) 134 (75.7) | - 6 (100) | - 5 (100) | - 5 (100) | 26 (61.9) 16 (38.1) | 13 (15.1) 73 (84.9) | - 33 (100) |
-
*
One study provided results by outcome not by studies being replicated, in this instance we were unable to determine how the results corresponded to the studies the author listed they replicated so these data are missing.
-
†
In these instances authors specified deviations between their protocol and that of the original research team.
-
‡
This was not verified. We simply recorded what the authors reported. It is possible that self-reported sharing and rates of actual sharing are not identical.
Table 3
Reproducibility characteristics of studies replicated overall and across disciplines.
Characteristic | Categories | Overall | Biomedicine | Economics | Education | Health sciences | Psychology | Other |
---|---|---|---|---|---|---|---|---|
How did the authors assess reproducibility? | Effect sizes Meta analysis of original effect size Null hypothesis testing using p-value Subjective assessment Other | 116 (65.5) 33 (18.6) 17 (9.6) 5 (2.8) 6 (3.4) | 1 (16.7) 2 (33.3) 2 (33.3) - 1 (16.7) | 1 (20.0) - 2 (40.0) 1 (20.0) 1 (20.0) | 1 (20.0) - - 2 (40.0) 2 (40.0) | 25 (59.5) 9 (21.4) 5 (11.9) 2 (4.8) 1 (2.4) | 76 (88.4) 1 (1.2) 8 (9.3) - 1 (1.2) | 12 (36.4) 21 (63.6) - - - |
Based on the authors definition of reproducibility, did the study replicate? | Yes No Mixed Unclear | 95 (53.7) 36 (20.3) 8 (4.5) 38 (21.5) | 4 (66.7) 1 (16.7) 1 (16.7) - | 4 (80.0) 1 (20.0) - - | 2 (40.0) 2 (40.0) 1 (20.0) - | 36 (85.7) 4 (9.5) 1 (2.4) 1 (2.4) | 25 (29.1) 19 (22.1) 5 (5.8) 37 (43.0) | 24 (72.7) 9 (27.3) - - |
Was the p-value reported on the statistical test conducted on the primary outcome? | Yes No/unclear | 116 (65.5) 61 (34.5) | 3 (50.0) 3 (50.0) | 3 (60.0) 2 (40.0) | 4 (80.0) 1 (20.0) | 33 (78.6) 9 (21.4) | 45 (52.3) 41 (47.7) | 28 (84.8) 5 (15.2) |
Additional files
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Epidemiological characteristics and prevalence rates of research reproducibility across disciplines: A scoping review of articles published in 2018-2019
eLife 12:e78518.
https://doi.org/10.7554/eLife.78518